Adds tianeptine sodium to the list of Schedule II of controlled substances

This bill adds tianeptine sodium to New York's Schedule II controlled substances list, which includes drugs with high abuse potential but recognized medical uses (like certain opioids). It directly affects healthcare providers who prescribe it, pharmacies that dispense it, and patients who use it, requiring stricter controls such as special prescriptions and recordkeeping. The law amends the public health law to include tianeptine sodium in Schedule II, aligning its regulation with other high-risk medications. The change takes effect 90 days after enactment.